nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPN4—bronchus—chronic obstructive pulmonary disease	0.0281	0.128	CbGeAlD
Alendronate—PTPRS—connective tissue—chronic obstructive pulmonary disease	0.0257	0.117	CbGeAlD
Alendronate—PTPRE—lung—chronic obstructive pulmonary disease	0.019	0.0868	CbGeAlD
Alendronate—PTPN4—lung—chronic obstructive pulmonary disease	0.0181	0.0826	CbGeAlD
Alendronate—ATP6V1A—respiratory system—chronic obstructive pulmonary disease	0.0169	0.0769	CbGeAlD
Alendronate—PTPRS—lung—chronic obstructive pulmonary disease	0.0155	0.0708	CbGeAlD
Alendronate—ATP6V1A—bronchus—chronic obstructive pulmonary disease	0.0139	0.0633	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—CRP—chronic obstructive pulmonary disease	0.0138	0.117	CbGpPWpGaD
Alendronate—FDPS—respiratory system—chronic obstructive pulmonary disease	0.0127	0.0579	CbGeAlD
Alendronate—ATP6V1A—trachea—chronic obstructive pulmonary disease	0.0125	0.0568	CbGeAlD
Alendronate—PTPRS—ECM proteoglycans—TGFB2—chronic obstructive pulmonary disease	0.0123	0.104	CbGpPWpGaD
Alendronate—FDPS—connective tissue—chronic obstructive pulmonary disease	0.0112	0.051	CbGeAlD
Alendronate—FDPS—bronchus—chronic obstructive pulmonary disease	0.0104	0.0477	CbGeAlD
Alendronate—FDPS—smooth muscle tissue—chronic obstructive pulmonary disease	0.0102	0.0466	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.00986	0.0833	CbGpPWpGaD
Alendronate—FDPS—trachea—chronic obstructive pulmonary disease	0.00938	0.0428	CbGeAlD
Alendronate—ATP6V1A—lung—chronic obstructive pulmonary disease	0.00895	0.0408	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.00702	0.0594	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.00702	0.0594	CbGpPWpGaD
Alendronate—FDPS—lung—chronic obstructive pulmonary disease	0.00674	0.0307	CbGeAlD
Alendronate—PTPRS—ECM proteoglycans—SERPINE1—chronic obstructive pulmonary disease	0.00538	0.0455	CbGpPWpGaD
Alendronate—ATP6V1A—Iron uptake and transport—HMOX1—chronic obstructive pulmonary disease	0.00532	0.045	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—IL6—chronic obstructive pulmonary disease	0.00506	0.0428	CbGpPWpGaD
Alendronate—Gastrooesophageal reflux disease—Salbutamol—chronic obstructive pulmonary disease	0.00497	0.0075	CcSEcCtD
Alendronate—Melaena—Arformoterol—chronic obstructive pulmonary disease	0.00464	0.00701	CcSEcCtD
Alendronate—Melaena—Formoterol—chronic obstructive pulmonary disease	0.00464	0.00701	CcSEcCtD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS2—chronic obstructive pulmonary disease	0.00459	0.0388	CbGpPWpGaD
Alendronate—Musculoskeletal pain—Salbutamol—chronic obstructive pulmonary disease	0.00454	0.00686	CcSEcCtD
Alendronate—Impaired healing—Prednisone—chronic obstructive pulmonary disease	0.00433	0.00653	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.00429	0.0363	CbGpPWpGaD
Alendronate—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00401	0.00605	CcSEcCtD
Alendronate—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00394	0.00594	CcSEcCtD
Alendronate—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00392	0.00592	CcSEcCtD
Alendronate—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0038	0.00574	CcSEcCtD
Alendronate—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00374	0.00565	CcSEcCtD
Alendronate—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.0037	0.00558	CcSEcCtD
Alendronate—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00369	0.00558	CcSEcCtD
Alendronate—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—chronic obstructive pulmonary disease	0.00369	0.0312	CbGpPWpGaD
Alendronate—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00368	0.00555	CcSEcCtD
Alendronate—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.00366	0.00552	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.0035	0.0296	CbGpPWpGaD
Alendronate—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00349	0.00526	CcSEcCtD
Alendronate—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00345	0.0052	CcSEcCtD
Alendronate—PTPRS—ECM proteoglycans—TGFB1—chronic obstructive pulmonary disease	0.0034	0.0287	CbGpPWpGaD
Alendronate—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00332	0.00501	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00327	0.0276	CbGpPWpGaD
Alendronate—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00321	0.00485	CcSEcCtD
Alendronate—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00316	0.00478	CcSEcCtD
Alendronate—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00316	0.00478	CcSEcCtD
Alendronate—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00311	0.00469	CcSEcCtD
Alendronate—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00311	0.00469	CcSEcCtD
Alendronate—Gastritis—Arformoterol—chronic obstructive pulmonary disease	0.00305	0.00461	CcSEcCtD
Alendronate—Gastritis—Formoterol—chronic obstructive pulmonary disease	0.00305	0.00461	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00305	0.0046	CcSEcCtD
Alendronate—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00304	0.0046	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00304	0.0046	CcSEcCtD
Alendronate—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00298	0.0045	CcSEcCtD
Alendronate—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00298	0.0045	CcSEcCtD
Alendronate—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00294	0.00444	CcSEcCtD
Alendronate—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00443	CcSEcCtD
Alendronate—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00292	0.00441	CcSEcCtD
Alendronate—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.0044	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00291	0.0246	CbGpPWpGaD
Alendronate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00286	0.00431	CcSEcCtD
Alendronate—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.00428	CcSEcCtD
Alendronate—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00282	0.00425	CcSEcCtD
Alendronate—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00277	0.00418	CcSEcCtD
Alendronate—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00275	0.00416	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—KL—chronic obstructive pulmonary disease	0.00275	0.0233	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00273	0.00413	CcSEcCtD
Alendronate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00266	0.00401	CcSEcCtD
Alendronate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00264	0.00399	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00258	0.0039	CcSEcCtD
Alendronate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00246	0.00372	CcSEcCtD
Alendronate—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00245	0.0037	CcSEcCtD
Alendronate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0024	0.00362	CcSEcCtD
Alendronate—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00355	CcSEcCtD
Alendronate—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00355	CcSEcCtD
Alendronate—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00355	CcSEcCtD
Alendronate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00229	0.00345	CcSEcCtD
Alendronate—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00342	CcSEcCtD
Alendronate—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.0034	CcSEcCtD
Alendronate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00221	0.00334	CcSEcCtD
Alendronate—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00221	0.00334	CcSEcCtD
Alendronate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00221	0.00334	CcSEcCtD
Alendronate—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00331	CcSEcCtD
Alendronate—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00219	0.00331	CcSEcCtD
Alendronate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00213	0.00321	CcSEcCtD
Alendronate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.00318	CcSEcCtD
Alendronate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00211	0.00318	CcSEcCtD
Alendronate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00209	0.00316	CcSEcCtD
Alendronate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00209	0.00315	CcSEcCtD
Alendronate—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00307	CcSEcCtD
Alendronate—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00307	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.00202	0.0171	CbGpPWpGaD
Alendronate—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00302	CcSEcCtD
Alendronate—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.002	0.00302	CcSEcCtD
Alendronate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00199	0.003	CcSEcCtD
Alendronate—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00198	0.00299	CcSEcCtD
Alendronate—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00196	0.00296	CcSEcCtD
Alendronate—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00196	0.00295	CcSEcCtD
Alendronate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00292	CcSEcCtD
Alendronate—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00291	CcSEcCtD
Alendronate—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00291	CcSEcCtD
Alendronate—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.0029	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00289	CcSEcCtD
Alendronate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00287	CcSEcCtD
Alendronate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00287	CcSEcCtD
Alendronate—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00285	CcSEcCtD
Alendronate—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00283	CcSEcCtD
Alendronate—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00283	CcSEcCtD
Alendronate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00281	CcSEcCtD
Alendronate—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00279	CcSEcCtD
Alendronate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00275	CcSEcCtD
Alendronate—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00275	CcSEcCtD
Alendronate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.0018	0.00271	CcSEcCtD
Alendronate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00271	CcSEcCtD
Alendronate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00267	CcSEcCtD
Alendronate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00267	CcSEcCtD
Alendronate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00267	CcSEcCtD
Alendronate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00267	CcSEcCtD
Alendronate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00267	CcSEcCtD
Alendronate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00267	CcSEcCtD
Alendronate—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00266	CcSEcCtD
Alendronate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00266	CcSEcCtD
Alendronate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00266	CcSEcCtD
Alendronate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00264	CcSEcCtD
Alendronate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00264	CcSEcCtD
Alendronate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00262	CcSEcCtD
Alendronate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00259	CcSEcCtD
Alendronate—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00259	CcSEcCtD
Alendronate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00171	0.00258	CcSEcCtD
Alendronate—Infection—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00254	CcSEcCtD
Alendronate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00254	CcSEcCtD
Alendronate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00252	CcSEcCtD
Alendronate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00252	CcSEcCtD
Alendronate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00252	CcSEcCtD
Alendronate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00251	CcSEcCtD
Alendronate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00249	CcSEcCtD
Alendronate—Infection—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00249	CcSEcCtD
Alendronate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00248	CcSEcCtD
Alendronate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00163	0.00246	CcSEcCtD
Alendronate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.0024	CcSEcCtD
Alendronate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00238	CcSEcCtD
Alendronate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00234	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00233	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00233	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.00154	0.013	CbGpPWpGaD
Alendronate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.0023	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00229	CcSEcCtD
Alendronate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00225	CcSEcCtD
Alendronate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00225	CcSEcCtD
Alendronate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00224	CcSEcCtD
Alendronate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00147	0.00222	CcSEcCtD
Alendronate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00221	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.0022	CcSEcCtD
Alendronate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00219	CcSEcCtD
Alendronate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00219	CcSEcCtD
Alendronate—Pain—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00219	CcSEcCtD
Alendronate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00219	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00144	0.0122	CbGpPWpGaD
Alendronate—Pain—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00214	CcSEcCtD
Alendronate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00214	CcSEcCtD
Alendronate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00213	CcSEcCtD
Alendronate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00212	CcSEcCtD
Alendronate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00212	CcSEcCtD
Alendronate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00211	CcSEcCtD
Alendronate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00211	CcSEcCtD
Alendronate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00211	CcSEcCtD
Alendronate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.0021	CcSEcCtD
Alendronate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00209	CcSEcCtD
Alendronate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00209	CcSEcCtD
Alendronate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00207	CcSEcCtD
Alendronate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00207	CcSEcCtD
Alendronate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00205	CcSEcCtD
Alendronate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00203	CcSEcCtD
Alendronate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00203	CcSEcCtD
Alendronate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00202	CcSEcCtD
Alendronate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00202	CcSEcCtD
Alendronate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00202	CcSEcCtD
Alendronate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00202	CcSEcCtD
Alendronate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00202	CcSEcCtD
Alendronate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.002	CcSEcCtD
Alendronate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.002	CcSEcCtD
Alendronate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.002	CcSEcCtD
Alendronate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00199	CcSEcCtD
Alendronate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00199	CcSEcCtD
Alendronate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00199	CcSEcCtD
Alendronate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00198	CcSEcCtD
Alendronate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00198	CcSEcCtD
Alendronate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00198	CcSEcCtD
Alendronate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00196	CcSEcCtD
Alendronate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00195	CcSEcCtD
Alendronate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00192	CcSEcCtD
Alendronate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00191	CcSEcCtD
Alendronate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00191	CcSEcCtD
Alendronate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00189	CcSEcCtD
Alendronate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00189	CcSEcCtD
Alendronate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00188	CcSEcCtD
Alendronate—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00188	CcSEcCtD
Alendronate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00185	CcSEcCtD
Alendronate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00184	CcSEcCtD
Alendronate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00184	CcSEcCtD
Alendronate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00181	CcSEcCtD
Alendronate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00181	CcSEcCtD
Alendronate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.0018	CcSEcCtD
Alendronate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00178	CcSEcCtD
Alendronate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00178	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.00118	0.00994	CbGpPWpGaD
Alendronate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00177	CcSEcCtD
Alendronate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00175	CcSEcCtD
Alendronate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00175	CcSEcCtD
Alendronate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00173	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00114	0.00964	CbGpPWpGaD
Alendronate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00172	CcSEcCtD
Alendronate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00171	CcSEcCtD
Alendronate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.0017	CcSEcCtD
Alendronate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00169	CcSEcCtD
Alendronate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00169	CcSEcCtD
Alendronate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00166	CcSEcCtD
Alendronate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00165	CcSEcCtD
Alendronate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00163	CcSEcCtD
Alendronate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00163	CcSEcCtD
Alendronate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00161	CcSEcCtD
Alendronate—Rash—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00161	CcSEcCtD
Alendronate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00161	CcSEcCtD
Alendronate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00161	CcSEcCtD
Alendronate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.0016	CcSEcCtD
Alendronate—Headache—Formoterol—chronic obstructive pulmonary disease	0.00106	0.0016	CcSEcCtD
Alendronate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.0016	CcSEcCtD
Alendronate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00159	CcSEcCtD
Alendronate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00158	CcSEcCtD
Alendronate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00158	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00158	CcSEcCtD
Alendronate—Headache—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00157	CcSEcCtD
Alendronate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00155	CcSEcCtD
Alendronate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00154	CcSEcCtD
Alendronate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00153	CcSEcCtD
Alendronate—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00153	CcSEcCtD
Alendronate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00152	CcSEcCtD
Alendronate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00152	CcSEcCtD
Alendronate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00152	CcSEcCtD
Alendronate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00152	CcSEcCtD
Alendronate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00151	CcSEcCtD
Alendronate—FDPS—Metabolism—APIP—chronic obstructive pulmonary disease	0.000997	0.00843	CbGpPWpGaD
Alendronate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000987	0.00149	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000969	0.00819	CbGpPWpGaD
Alendronate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000952	0.00144	CcSEcCtD
Alendronate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000947	0.00143	CcSEcCtD
Alendronate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000945	0.00143	CcSEcCtD
Alendronate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00094	0.00142	CcSEcCtD
Alendronate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00083	0.00125	CcSEcCtD
Alendronate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000818	0.00123	CcSEcCtD
Alendronate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000786	0.00119	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000759	0.00115	CcSEcCtD
Alendronate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000757	0.00114	CcSEcCtD
Alendronate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000756	0.00114	CcSEcCtD
Alendronate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000748	0.00113	CcSEcCtD
Alendronate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000738	0.00111	CcSEcCtD
Alendronate—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000735	0.00111	CcSEcCtD
Alendronate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00073	0.0011	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000711	0.00601	CbGpPWpGaD
Alendronate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000696	0.00105	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000691	0.00584	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	0.000689	0.00582	CbGpPWpGaD
Alendronate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000688	0.00104	CcSEcCtD
Alendronate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000677	0.00102	CcSEcCtD
Alendronate—Infection—Prednisone—chronic obstructive pulmonary disease	0.000663	0.001	CcSEcCtD
Alendronate—FDPS—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000661	0.00559	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000655	0.00554	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GC—chronic obstructive pulmonary disease	0.000643	0.00543	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000641	0.00542	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000608	0.000918	CcSEcCtD
Alendronate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000608	0.000917	CcSEcCtD
Alendronate—FDPS—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000598	0.00505	CbGpPWpGaD
Alendronate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000588	0.000887	CcSEcCtD
Alendronate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.000874	CcSEcCtD
Alendronate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.000874	CcSEcCtD
Alendronate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000576	0.000869	CcSEcCtD
Alendronate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000571	0.000862	CcSEcCtD
Alendronate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00055	0.00083	CcSEcCtD
Alendronate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000546	0.000824	CcSEcCtD
Alendronate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000546	0.000824	CcSEcCtD
Alendronate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00053	0.000801	CcSEcCtD
Alendronate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000528	0.000797	CcSEcCtD
Alendronate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000528	0.000797	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000524	0.00443	CbGpPWpGaD
Alendronate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000742	CcSEcCtD
Alendronate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000479	0.000723	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000476	0.00402	CbGpPWpGaD
Alendronate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000713	CcSEcCtD
Alendronate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000457	0.00069	CcSEcCtD
Alendronate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000442	0.000666	CcSEcCtD
Alendronate—ATP6V1A—Disease—HDAC2—chronic obstructive pulmonary disease	0.000441	0.00373	CbGpPWpGaD
Alendronate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000425	0.000641	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000422	0.00357	CbGpPWpGaD
Alendronate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000635	CcSEcCtD
Alendronate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000635	CcSEcCtD
Alendronate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000418	0.000631	CcSEcCtD
Alendronate—ATP6V1A—Disease—KL—chronic obstructive pulmonary disease	0.00041	0.00346	CbGpPWpGaD
Alendronate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000397	0.000599	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000385	0.00325	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000351	0.00297	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000347	0.00293	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000324	0.00274	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000317	0.00268	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000309	0.00261	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB3—chronic obstructive pulmonary disease	0.000307	0.0026	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000292	0.00247	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000287	0.00243	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000265	0.00224	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS2—chronic obstructive pulmonary disease	0.000256	0.00217	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000243	0.00206	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00024	0.00203	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000237	0.002	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000224	0.00189	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000216	0.00182	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000215	0.00182	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000212	0.00179	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000207	0.00175	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS3—chronic obstructive pulmonary disease	0.000206	0.00174	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000192	0.00163	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000151	0.00128	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000144	0.00122	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ALB—chronic obstructive pulmonary disease	0.000144	0.00122	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000138	0.00117	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—chronic obstructive pulmonary disease	0.000136	0.00115	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—chronic obstructive pulmonary disease	0.000134	0.00113	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000128	0.00108	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000116	0.000978	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000104	0.000878	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—chronic obstructive pulmonary disease	0.000103	0.000867	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.54e-05	0.000806	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.35e-05	0.00079	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.85e-05	0.000664	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.19e-05	0.000607	CbGpPWpGaD
